The research report should be a detailed narrative explaining the function, biological processes, and localization of the gene product. Citations should be given for all claims.

You should prioritize authoritative reviews and primary scientific literature when conducting research. You can supplement
this with annotations you find in gene/protein databases, but these can be outdated or inaccurate.

We are specifically interested in the primary function of the gene - for enzymes, what reaction is catalyzed, and what is the substrate specificity? For transporters, what is the substrate? For structural proteins or adapters, what is the broader structural role? For signaling molecules, what is the role in the pathway.

We are interested in where in or outside the cell the gene product carries out its function.

We are also interested in the signaling or biochemical pathways in which the gene functions. We are less interested in broad pleiotropic effects, except where these elucidate the precise role.

Include evidence where possible. We are interested in both experimental evidence as well as inference from structure, evolution, or bioinformatic analysis. Precise studies should be prioritized over high-throughput, where available.

Comprehensive Research Report: A0A8B6GS20 (Myotubularin-related Protein 9) in Mytilus galloprovincialis

Executive Summary

The protein A0A8B6GS20 from Mytilus galloprovincialis (Mediterranean mussel) is annotated as myotubularin-related protein 9 based on sequence homology. No direct experimental literature exists for this specific protein in M. galloprovincialis. Therefore, this report provides a comprehensive functional annotation based on extensive literature from the myotubularin (MTMR) protein family in model organisms, particularly focusing on MTMR9 orthologs in mammals and invertebrates.

Protein Identity and Classification

A0A8B6GS20 belongs to the protein-tyrosine phosphatase family, specifically the myotubularin-related subfamily (saar2025themyotubularinrelated pages 1-2). The myotubularin family is highly conserved across eukaryotes, comprising 16 members in mammals (MTM1 and MTMR1-15), of which 9 are catalytically active phosphatases and 7 are catalytically inactive pseudophosphatases (allen2020aconservedmyotubularinrelated pages 1-2, manzeger2021conditiondependentfunctionalshift pages 1-4).

Based on its annotation as myotubularin-related protein 9, A0A8B6GS20 is predicted to be a catalytically inactive pseudophosphatase (wang2024recentadvancesof pages 2-3, liu2022theprogressof pages 3-5, reiterer2020thedeadphosphatases pages 25-28). Inactive myotubularins lack the catalytic cysteine residue in the conserved CX5R motif that is essential for phosphatase activity (allen2020aconservedmyotubularinrelated pages 1-2, manzeger2021conditiondependentfunctionalshift pages 1-4).

Primary Function: Regulatory Scaffold Protein

Lack of Direct Catalytic Activity

MTMR9 is classified as a pseudophosphatase because it lacks enzymatic activity toward phosphoinositides (liu2022theprogressof pages 3-5, reiterer2020thedeadphosphatases pages 25-28). Unlike catalytically active myotubularins that dephosphorylate phosphatidylinositol 3-phosphate [PI(3)P] and phosphatidylinositol 3,5-bisphosphate [PI(3,5)P2], MTMR9 cannot directly catalyze these reactions (wang2024recentadvancesof pages 2-3, reiterer2020thedeadphosphatases pages 25-28, manzeger2021conditiondependentfunctionalshift pages 1-4).

Regulatory Function Through Protein-Protein Interactions

The primary function of MTMR9 is to serve as a regulatory adaptor and scaffold protein that modulates the activity, localization, and substrate specificity of catalytically active myotubularins (wang2024recentadvancesof pages 2-3, liu2022theprogressof pages 3-5, saar2025themyotubularinrelated pages 1-2). MTMR9 forms heterodimeric complexes with active myotubularins, specifically MTMR6, MTMR7, and MTMR8, through coiled-coil domain interactions (wang2024recentadvancesof pages 2-3, liu2022theprogressof pages 3-5, saar2025themyotubularinrelated pages 1-2).

Recent structural and biochemical studies demonstrate that MTMR9 can both homodimerize and heterodimerize with active partners (wang2024recentadvancesof pages 2-3, saar2025themyotubularinrelated pages 1-2). The coiled-coil domain of MTMR7 preferentially forms dimers, while MTMR9 coiled-coil domains can form trimers, indicating complex oligomerization states that may regulate function (saar2025themyotubularinrelated pages 1-2).

Substrate Specificity Modulation

When MTMR9 forms heterodimeric complexes with active myotubularins, it can alter the substrate preference of the complex. For example, the MTMR8/MTMR9 complex preferentially acts on PI(3)P as substrate, while other MTMR complexes may have broader specificity toward both PI(3)P and PI(3,5)P2 (wang2024recentadvancesof pages 2-3, wang2024recentadvancesof pages 3-4). This partner-mediated substrate selectivity allows for fine-tuned regulation of phosphoinositide metabolism in different cellular compartments.

Table: This table summarizes catalytic status, substrates, reactions, interactions, localization, and biological roles across the myotubularin family, with emphasis on MTMR9 as a pseudophosphatase. It is useful for inferring the likely function of the mussel protein A0A8B6GS20 when direct organism-specific literature is unavailable.

Biochemical Context: Phosphoinositide Metabolism

The Myotubularin Family Catalytic Mechanism

Active myotubularins catalyze the removal of the 3-phosphate group from phosphoinositides (saar2025themyotubularinrelated pages 1-2, moschovakifilippidou2025lackofmyotubularin pages 1-5, manzeger2021conditiondependentfunctionalshift pages 1-4). Specifically, they convert:
- PI(3)P → PI (phosphatidylinositol)
- PI(3,5)P2 → PI(5)P (phosphatidylinositol 5-phosphate)

These reactions are critical for regulating membrane identity and trafficking, as different phosphoinositides recruit distinct sets of effector proteins (allen2020aconservedmyotubularinrelated pages 1-2, licheva2022phosphoregulationofthe pages 3-4, manzeger2021conditiondependentfunctionalshift pages 1-4).

Phosphoinositide Signaling Networks

Myotubularins function antagonistically to Class III phosphatidylinositol 3-kinases (PI3K) such as VPS34/PIK3C3, which generate PI(3)P from PI (licheva2022phosphoregulationofthe pages 3-4, manzeger2021conditiondependentfunctionalshift pages 1-4). The balance between kinase-mediated phosphorylation and myotubularin-mediated dephosphorylation determines the steady-state levels of these signaling lipids on different membrane compartments (wang2024recentadvancesof pages 3-4, moschovakifilippidou2025lackofmyotubularin pages 1-5, lange2024myotubularinrelatedproteinsregulate pages 1-5).

Loss or reduction of myotubularin activity leads to accumulation of PI(3)P on membranes, which has profound consequences for downstream signaling pathways including mTOR/AKT signaling and autophagy regulation (wang2024recentadvancesof pages 3-4, moschovakifilippidou2025lackofmyotubularin pages 1-5, lange2024myotubularinrelatedproteinsregulate pages 1-5).

Subcellular Localization

MTMR9 Localization in Mammalian Cells

In mammalian cells, MTMR9 recruits its catalytically active binding partners MTMR6 and MTMR8 to specific subcellular compartments, particularly the intermediate compartment between the endoplasmic reticulum (ER) and Golgi apparatus (liu2022theprogressof pages 3-5, saar2025themyotubularinrelated pages 1-2). This recruitment function is essential for maintaining Golgi integrity and regulating ER-to-Golgi transport (liu2022theprogressof pages 3-5).

The MTMR6-MTMR9 and MTMR8-MTMR9 heterodimers are confirmed to localize to these membrane compartments where they regulate local phosphoinositide composition (wang2024recentadvancesof pages 2-3, liu2022theprogressof pages 3-5, saar2025themyotubularinrelated pages 1-2).

General MTMR Family Localization

The broader myotubularin family shows diverse subcellular distributions, with different members localizing to:
- Endosomes (early and late)
- Autophagic membranes (phagophores, autophagosomes, autolysosomes)
- Lysosomes
- Nuclear envelope
- Plasma membrane-associated compartments
- Golgi apparatus and intermediate compartment
- Cytosol

This diversity reflects the specialized functions of different family members in regulating phosphoinositide composition at distinct cellular locations (liu2022theprogressof pages 3-5, allen2020aconservedmyotubularinrelated pages 1-2, saar2025themyotubularinrelated pages 1-2).

Biological Processes and Signaling Pathways

ER-to-Golgi Trafficking and Golgi Integrity

The most well-characterized function of MTMR9 is its role in ER-to-Golgi membrane trafficking (liu2022theprogressof pages 3-5). MTMR9 recruits MTMR6 and MTMR8 to the intermediate compartment and Golgi apparatus, forming functional dimers that regulate the transport of cargo from the ER to the Golgi and maintain Golgi structural integrity (liu2022theprogressof pages 3-5, saar2025themyotubularinrelated pages 1-2).

This function requires precise regulation of phosphoinositide levels, particularly PI(3)P, at ER-Golgi contact sites. Disruption of MTMR9 function impairs these trafficking pathways (liu2022theprogressof pages 3-5).

Autophagy Regulation

Myotubularins play critical roles in autophagy, the cellular self-degradation pathway essential for protein and organelle quality control (allen2020aconservedmyotubularinrelated pages 1-2, chua2022myotubularinrelatedphosphatase5 pages 1-4, licheva2022phosphoregulationofthe pages 3-4, allen2020identificationofa pages 1-9, manzeger2021conditiondependentfunctionalshift pages 1-4). The regulation of autophagy by myotubularins is complex and context-dependent:

Active myotubularins regulate autophagic flux by controlling PI(3)P and PI(3,5)P2 levels on autophagic membranes (allen2020aconservedmyotubularinrelated pages 1-2, licheva2022phosphoregulationofthe pages 3-4, allen2020identificationofa pages 1-9). PI(3)P is required for autophagosome formation and maturation, while its timely removal is necessary for autophagosome-lysosome fusion and autolysosome reformation (allen2020aconservedmyotubularinrelated pages 1-2, licheva2022phosphoregulationofthe pages 3-4).

Studies in Drosophila demonstrate that myotubularin-related phosphatases (including MTMR6 orthologs) are essential for maintaining autophagic flux and lysosome homeostasis (allen2020aconservedmyotubularinrelated pages 1-2, allen2020identificationofa pages 1-9, manzeger2021conditiondependentfunctionalshift pages 1-4). Decreased function of these phosphatases results in autophagic vesicle accumulation and impaired cargo degradation (allen2020aconservedmyotubularinrelated pages 1-2, allen2020identificationofa pages 1-9).

MTMR9 complexes modulate autophagy through their effects on partner myotubularin activity. The heterodimer MTMR6-MTMR9 and MTMR8-MTMR9 complexes have been shown to regulate autophagy activity, with MTMR9 expression affecting autophagosome levels (wang2024recentadvancesof pages 2-3, wang2024recentadvancesof pages 3-4). Knockdown of both MTMR8 and MTMR9 results in increased levels of p62, a protein that accumulates when autophagy is impaired (liu2022theprogressof pages 3-5).

Studies in neurons reveal that MTMR5 (which interacts with MTMR2) suppresses autophagy by dephosphorylating phosphoinositides critical for autophagy initiation and autophagosome maturation, and knockdown of MTMR5 or MTMR2 (but not MTMR9) significantly enhances neuronal degradation of autophagy substrates (chua2022myotubularinrelatedphosphatase5 pages 1-4). This highlights the specificity of different MTMR complexes in autophagy regulation.

Endocytosis and Membrane Trafficking

Myotubularins regulate multiple aspects of membrane trafficking and endocytosis beyond autophagy (allen2020aconservedmyotubularinrelated pages 1-2, lange2024myotubularinrelatedproteinsregulate pages 1-5, allen2020identificationofa pages 1-9). Studies in Drosophila show that loss of myotubularin function impairs fluid-phase endocytosis in fat body cells and phagocytosis in embryonic macrophages (allen2020aconservedmyotubularinrelated pages 1-2, allen2020identificationofa pages 1-9).

The regulation of PI(3)P levels by myotubularins is critical for endosome maturation, receptor trafficking, and cargo sorting through the endolysosomal system (allen2020aconservedmyotubularinrelated pages 1-2, allen2020identificationofa pages 1-9).

Signaling Pathway Regulation

Myotubularins influence multiple signaling pathways through their effects on phosphoinositide metabolism:

PI3K/AKT Pathway: Myotubularins regulate the PI3K/AKT signaling pathway, which is critical for cell growth, survival, and metabolism (wang2024recentadvancesof pages 3-4). Silencing of active myotubularins (MTM1, MTMR2, MTMR3, MTMR4, MTMR7) leads to abnormal accumulation of PI(3)P, which can suppress AKT phosphorylation and downstream signaling (wang2024recentadvancesof pages 3-4).

KRAS Signaling: Recent studies demonstrate that myotubularins regulate KRAS function by controlling plasma membrane levels of phosphoinositides and phosphatidylserine (PtdSer) (lange2024myotubularinrelatedproteinsregulate pages 1-5). Silencing MTMR2/3/4/7 disrupts KRAS plasma membrane localization by depleting plasma membrane PI4P levels, which in turn affects PtdSer enrichment at the plasma membrane (lange2024myotubularinrelatedproteinsregulate pages 1-5). This reveals an indirect mechanism by which myotubularin-mediated PI(3)P dephosphorylation generates PI needed for PI4P synthesis, which is essential for KRAS membrane binding and oncogenic signaling (lange2024myotubularinrelatedproteinsregulate pages 1-5).

Apoptosis Regulation: The MTMR6-MTMR9 heterodimer has been shown to ameliorate cellular apoptosis both in vivo and in vitro (wang2024recentadvancesof pages 2-3).

Metabolic and Physiological Associations

Human genetic studies have identified associations between MTMR9 variants and metabolic traits. A single nucleotide polymorphism (SNP) in the MTMR9 gene intron is associated with increased HbA1c levels (wang2024recentadvancesof pages 3-4). MTMR9 expression in the murine hypothalamic region is elevated after fasting and decreased after a high-fat diet, suggesting involvement in metabolic regulation, obesity, and hypertension (liu2022theprogressof pages 3-5, wang2024recentadvancesof pages 3-4).

Evolutionary Conservation in Invertebrates

Myotubularins are evolutionarily conserved across eukaryotes, including invertebrates (allen2020identificationofa pages 1-9, manzeger2021conditiondependentfunctionalshift pages 1-4). Studies in Drosophila melanogaster provide important insights into myotubularin function in invertebrate systems:

Drosophila MTMR6 orthologs (dMtmr6/CG3530) function as regulators of autophagic flux and are required for development and viability (allen2020aconservedmyotubularinrelated pages 1-2, allen2020identificationofa pages 1-9, manzeger2021conditiondependentfunctionalshift pages 1-4). These proteins maintain lysosome homeostasis and regulate endocytosis and phagocytosis, demonstrating conserved functions across metazoans (allen2020aconservedmyotubularinrelated pages 1-2, allen2020identificationofa pages 1-9).

The condition-dependent regulation of autophagy by Drosophila myotubularins (EDTP and Mtmr6) reveals complex, context-specific functions: EDTP inhibits basal autophagy but does not influence stress-induced autophagy, while Mtmr6 promotes autophagy under nutrient-rich conditions but blocks its hyperactivation in response to stress (manzeger2021conditiondependentfunctionalshift pages 1-4). This demonstrates the sophisticated regulatory mechanisms employed by myotubularin family members.

The conservation of myotubularin structure and function from invertebrates to mammals strongly supports the inference that the mussel protein A0A8B6GS20 likely participates in similar phosphoinositide-regulated membrane biology processes (saar2025themyotubularinrelated pages 1-2, allen2020identificationofa pages 1-9, manzeger2021conditiondependentfunctionalshift pages 1-4).

Domain Architecture and Structural Features

Myotubularin family members share conserved domain architecture (saar2025themyotubularinrelated pages 1-2):

1. PH-GRAM domain: Binds phosphoinositides and mediates membrane association
2. Phosphatase domain: Contains the active site (CX5R motif in active enzymes; altered in pseudophosphatases)
3. Coiled-coil (CC) domain: Mediates homo- and hetero-oligomerization
4. C-terminal domain (CTD): Often intrinsically disordered regions containing short linear motifs (SLiMs) for protein interactions, subcellular targeting, and regulatory functions

Recent work reveals that myotubularin C-terminal domains are largely disordered and contain SLiMs important for targeting to subcellular compartments, interactions with diverse proteins including transcription factors, and involvement in signaling and phase separation (saar2025themyotubularinrelated pages 1-2). The coiled-coil domains mediate the critical protein-protein interactions between active and inactive myotubularins (wang2024recentadvancesof pages 2-3, saar2025themyotubularinrelated pages 1-2).

Inference for A0A8B6GS20 in Mytilus galloprovincialis

Based on the comprehensive literature review of myotubularin family proteins, the following functional predictions can be made for A0A8B6GS20:

Predicted Primary Function

A0A8B6GS20 is most likely a regulatory scaffold protein rather than a catalytically active phosphoinositide phosphatase (liu2022theprogressof pages 3-5, reiterer2020thedeadphosphatases pages 25-28, saar2025themyotubularinrelated pages 1-2). As an MTMR9 ortholog, it probably functions by forming heterodimeric complexes with catalytically active myotubularins present in M. galloprovincialis, modulating their localization, substrate specificity, and activity.

Predicted Biochemical Role

The protein likely regulates phosphoinositide metabolism indirectly through its effects on partner enzymes, rather than directly catalyzing dephosphorylation reactions (wang2024recentadvancesof pages 2-3, liu2022theprogressof pages 3-5, reiterer2020thedeadphosphatases pages 25-28).

Predicted Subcellular Localization

A0A8B6GS20 is predicted to localize to membrane trafficking compartments, particularly those involved in secretory pathway organization (ER-Golgi intermediate compartment, Golgi apparatus) and/or endolysosomal compartments, depending on its binding partners (liu2022theprogressof pages 3-5, saar2025themyotubularinrelated pages 1-2).

Predicted Biological Processes

The protein is likely involved in:
- Membrane trafficking and secretory pathway function (ER-to-Golgi transport, Golgi organization)
- Autophagy regulation (potentially modulating autophagic flux)
- Endolysosomal homeostasis
- Cellular signaling through effects on phosphoinositide-dependent pathways

These predictions are based on the conserved functions of MTMR9 orthologs in mammals and invertebrates (liu2022theprogressof pages 3-5, allen2020aconservedmyotubularinrelated pages 1-2, saar2025themyotubularinrelated pages 1-2, allen2020identificationofa pages 1-9, manzeger2021conditiondependentfunctionalshift pages 1-4).

Limitations and Future Directions

Critical limitation: No direct experimental data exists for A0A8B6GS20 in Mytilus galloprovincialis. All functional annotations are inferred from orthologous proteins in model organisms.

Recommended experimental approaches to validate these predictions:
1. Biochemical characterization of phosphatase activity (or lack thereof)
2. Identification of binding partners in mussel cells
3. Subcellular localization studies
4. Functional knockdown/knockout studies examining effects on membrane trafficking and autophagy
5. Analysis of phosphoinositide levels in cells with altered A0A8B6GS20 expression

Conclusion

A0A8B6GS20 from Mytilus galloprovincialis is annotated as myotubularin-related protein 9 based on sequence homology. Drawing from extensive literature on the myotubularin family, this protein is predicted to function as a catalytically inactive regulatory scaffold that modulates the activity of catalytically active myotubularin phosphatases through protein-protein interactions. Its primary role is likely in membrane trafficking, particularly ER-to-Golgi transport and Golgi organization, with potential involvement in autophagy regulation and endolysosomal homeostasis. Rather than directly catalyzing phosphoinositide dephosphorylation, A0A8B6GS20 likely regulates these processes by controlling the localization and substrate specificity of active myotubularin partners. These predictions are strongly supported by evolutionary conservation of myotubularin function from invertebrates to mammals, but await direct experimental validation in the mussel system.

References

1. (saar2025themyotubularinrelated pages 1-2): Daniel Saar, Caroline L. E. Lennartsson, Philip Weidner, Elke Burgermeister, and Birthe B. Kragelund. The myotubularin related proteins and the untapped interaction potential of their disordered c‐terminal regions. Proteins, 93:831-854, Nov 2025. URL: https://doi.org/10.1002/prot.26774, doi:10.1002/prot.26774. This article has 5 citations.

2. (allen2020aconservedmyotubularinrelated pages 1-2): Elizabeth A. Allen, Clelia Amato, Tina M. Fortier, Panagiotis Velentzas, Will Wood, and Eric H. Baehrecke. A conserved myotubularin-related phosphatase regulates autophagy by maintaining autophagic flux. The Journal of Cell Biology, Sep 2020. URL: https://doi.org/10.1083/jcb.201909073, doi:10.1083/jcb.201909073. This article has 33 citations.

3. (manzeger2021conditiondependentfunctionalshift pages 1-4): Anna Manzéger, Kinga Tagscherer, Péter Lőrincz, Henrik Szaker, Tamás Lukácsovich, Petra Pilz, Regina Kméczik, George Csikós, Miklós Erdélyi, Miklós Sass, Tibor Kovács, Tibor Vellai, and Viktor A. Billes. Condition-dependent functional shift of two drosophila mtmr lipid phosphatases in autophagy control. Autophagy, 17:4010-4028, Mar 2021. URL: https://doi.org/10.1080/15548627.2021.1899681, doi:10.1080/15548627.2021.1899681. This article has 17 citations and is from a domain leading peer-reviewed journal.

4. (wang2024recentadvancesof pages 2-3): Jia Wang, Wei Guo, Qiang Wang, Yongjian Yang, and Xiongshan Sun. Recent advances of myotubularin-related (mtmr) protein family in cardiovascular diseases. Frontiers in Cardiovascular Medicine, Mar 2024. URL: https://doi.org/10.3389/fcvm.2024.1364604, doi:10.3389/fcvm.2024.1364604. This article has 16 citations and is from a peer-reviewed journal.

5. (liu2022theprogressof pages 3-5): Deqiang Liu, Yiming Zhang, Hui Fang, Jinxiang Yuan, and Lizhen Ji. The progress of research into pseudophosphatases. Frontiers in Public Health, Aug 2022. URL: https://doi.org/10.3389/fpubh.2022.965631, doi:10.3389/fpubh.2022.965631. This article has 4 citations.

6. (reiterer2020thedeadphosphatases pages 25-28): Veronika Reiterer, Krzysztof Pawłowski, Guillaume Desrochers, Arnim Pause, Hayley J. Sharpe, and Hesso Farhan. The dead phosphatases society: a review of the emerging roles of pseudophosphatases. The FEBS Journal, 287:4198-4220, Jun 2020. URL: https://doi.org/10.1111/febs.15431, doi:10.1111/febs.15431. This article has 37 citations.

7. (wang2024recentadvancesof pages 3-4): Jia Wang, Wei Guo, Qiang Wang, Yongjian Yang, and Xiongshan Sun. Recent advances of myotubularin-related (mtmr) protein family in cardiovascular diseases. Frontiers in Cardiovascular Medicine, Mar 2024. URL: https://doi.org/10.3389/fcvm.2024.1364604, doi:10.3389/fcvm.2024.1364604. This article has 16 citations and is from a peer-reviewed journal.

8. (moschovakifilippidou2025lackofmyotubularin pages 1-5): Foteini Moschovaki-Filippidou, Christine Kretz, David Reiss, Gaëtan Chicanne, Bernard Payrastre, and Jocelyn Laporte. Lack of myotubularin phosphatase activity is the main cause of x-linked myotubular myopathy. JCI Insight, Oct 2025. URL: https://doi.org/10.1172/jci.insight.189286, doi:10.1172/jci.insight.189286. This article has 1 citations and is from a domain leading peer-reviewed journal.

9. (licheva2022phosphoregulationofthe pages 3-4): Mariya Licheva, Babu Raman, Claudine Kraft, and Fulvio Reggiori. Phosphoregulation of the autophagy machinery by kinases and phosphatases. Autophagy, 18:104-123, May 2022. URL: https://doi.org/10.1080/15548627.2021.1909407, doi:10.1080/15548627.2021.1909407. This article has 87 citations and is from a domain leading peer-reviewed journal.

10. (lange2024myotubularinrelatedproteinsregulate pages 1-5): Taylor E. Lange, Ali Naji, Ransome van der Hoeven, Hong Liang, Yong Zhou, Gerald R.V. Hammond, John F. Hancock, and Kwang-jin Cho. Myotubularin-related proteins regulate kras function by controlling plasma membrane levels of polyphosphoinositides and phosphatidylserine. bioRxiv, Jan 2024. URL: https://doi.org/10.1101/2024.01.22.576612, doi:10.1101/2024.01.22.576612. This article has 1 citations.

11. (allen2020identificationofa pages 1-9): Elizabeth Allen. Identification of a myotubularin-related phosphatase that regulates autophagic flux and lysosome homeostasis. ArXiv, 2020. URL: https://doi.org/10.13028/ag58-jw39, doi:10.13028/ag58-jw39. This article has 0 citations.

12. (chua2022myotubularinrelatedphosphatase5 pages 1-4): Jason P. Chua, Karan Bedi, Michelle T. Paulsen, Mats Ljungman, Elizabeth M. H. Tank, Erin S. Kim, Jennifer M. Colón-Mercado, Michael E. Ward, Lois S. Weisman, and Sami J. Barmada. Myotubularin-related phosphatase 5 is a critical determinant of autophagy in neurons. Current Biology, 32:2581-2595.e6, Jul 2022. URL: https://doi.org/10.1101/2021.07.20.453106, doi:10.1101/2021.07.20.453106. This article has 34 citations and is from a highest quality peer-reviewed journal.

Artifacts

• Edison artifact artifact-00

Citations

1. saar2025themyotubularinrelated pages 1-2
2. manzeger2021conditiondependentfunctionalshift pages 1-4
3. liu2022theprogressof pages 3-5
4. wang2024recentadvancesof pages 3-4
5. lange2024myotubularinrelatedproteinsregulate pages 1-5
6. wang2024recentadvancesof pages 2-3
7. allen2020aconservedmyotubularinrelated pages 1-2
8. reiterer2020thedeadphosphatases pages 25-28
9. moschovakifilippidou2025lackofmyotubularin pages 1-5
10. licheva2022phosphoregulationofthe pages 3-4
11. allen2020identificationofa pages 1-9
12. PI(3)P
13. PI(3,5)P2
14. https://doi.org/10.1002/prot.26774,
15. https://doi.org/10.1083/jcb.201909073,
16. https://doi.org/10.1080/15548627.2021.1899681,
17. https://doi.org/10.3389/fcvm.2024.1364604,
18. https://doi.org/10.3389/fpubh.2022.965631,
19. https://doi.org/10.1111/febs.15431,
20. https://doi.org/10.1172/jci.insight.189286,
21. https://doi.org/10.1080/15548627.2021.1909407,
22. https://doi.org/10.1101/2024.01.22.576612,
23. https://doi.org/10.13028/ag58-jw39,
24. https://doi.org/10.1101/2021.07.20.453106,

AIGR Gene Hypothesis Deep Research — Final Report

Target gene: A0A8B6GS20 (Mytilus galloprovincialis, MYTGA, NCBITaxon:29158)
UniProt automated name: Myotubularin-related protein 9 (ECO:0000313 / EMBL VDI68180.1)
Length: 607 aa
Hypothesis under test: ProtNLM2 predicts phosphatidylinositol-3-phosphate phosphatase activity (GO:0004438).
Focus type: computational_prediction

Verdict: REFUTED (over-annotation)

Summary

The ProtNLM2 prediction that Mytilus galloprovincialis protein A0A8B6GS20 possesses phosphatidylinositol-3-phosphate phosphatase activity (GO:0004438) is refuted by direct inspection of the catalytic machinery required for that activity. Myotubularins are members of the protein-tyrosine-phosphatase (PTP) superfamily, and every catalytically active myotubularin dephosphorylates PtdIns3P (and PtdIns(3,5)P₂) using a strictly conserved P-loop of the form CX₅R(T/S), in which a nucleophilic cysteine forms the covalent phospho-enzyme intermediate and a downstream arginine stabilizes the transition-state oxyanion. Loss of the catalytic cysteine is the defining, diagnostic lesion that separates active myotubularins from the "pseudophosphatase" members of the family.

In A0A8B6GS20 the P-loop is present in fold but degenerate in substance. Anchored on the invariant myotubularin histidine scaffold (V.VH-[Cx5R]), active human orthologs read VLVH-CSDGWDRT (MTM1; catalytic Cys375/Arg381) and VVVH-CSDGWDRT (MTMR2; catalytic Cys417). The aligned segment in the Mytilus target reads VLVH-GSEGFDTT: the catalytic nucleophilic cysteine is replaced by glycine (C→G) and the catalytic arginine by threonine (R→T). A whole-protein scan for any CX₅R motif found only a single incidental match (CNNEKER at Cys485) that lacks the obligatory downstream Thr/Ser, is not at the P-loop position, and sits in a charged surface loop — i.e., there is no intact, correctly positioned CX₅R(T/S) catalytic motif anywhere in the 607-residue sequence. Because there is no active-site thiolate to attack the 3-phosphate, intrinsic PI3P dephosphorylation is mechanistically impossible.

This assignment is fully consistent with the biology of the protein's named human ortholog, MTMR9, a textbook catalytically dead pseudophosphatase that functions as a regulatory adaptor for active myotubularin partners (MTMR6, MTMR7, MTMR8) rather than as an enzyme in its own right. The recommended curation action is therefore to not assign GO:0004438 as a direct molecular function; the biologically supported alternative is a non-catalytic pseudophosphatase / adaptor role. Two caveats temper the peripheral details without changing the core verdict: (1) k-mer similarity was too weak to confirm the exact human paralog, so the specific "MTMR9" name is provisional; and (2) the target carries an atypical N-terminal architecture (zona-pellucida/D8C_UMOD-like repeats, IPR057774/PF23283) absent from vertebrate MTMR9, raising questions about the gene model or a divergent mollusc architecture. Neither caveat rescues the missing catalytic residues.

Key Findings

Finding 1 — The catalytic P-loop is degenerate: the target is a pseudophosphatase (refutes the prediction)

The decisive computational test is whether the residues required for PI3P phosphatase catalysis are present and correctly spaced. Myotubularin fold membership is not in dispute — A0A8B6GS20 is annotated through multiple orthogonal signatures (InterPro IPR030564 Myotubularin; IPR010569 Myotubularin-like phosphatase domain; IPR029021 PTP-like; PROSITE PS51339 PPASE_MYOTUBULARIN; Pfam PF06602 Myotub-related). The question is purely catalytic competence within that fold.

Anchoring on the conserved myotubularin P-loop scaffold V.VH-[Cx5R], the alignment is unambiguous:

Position-by-position, the P-loop reads C→G, S→S, D→E, G→G, W→F, D→D, R→T, T→T — both catalytic residues are lost. A full-protein regular-expression scan for C.{5}R returned exactly one match, CNNEKER at Cys485, which (a) lacks the required downstream Thr/Ser, (b) is not at the structural P-loop position, and (c) lies in a charged loop. No functional CX₅R(T/S) P-loop exists anywhere in the protein. This is the signature of a catalytically dead myotubularin pseudophosphatase and directly refutes the GO:0004438 prediction.

The interpretation is anchored to primary literature. PMID: 22647598 states that within the family, "Seven members are inactive because they lack the conserved cysteine residue in the CX(5)R motif required for activity" — precisely the lesion observed here (C→G). The same study confirms the named ortholog is inactive: active MTMRs are "all of which dimerize with the catalytically inactive MTMR9." Independent work (PMID: 31704058) reinforces this, describing that "the inactive phosphatase MTMR9 localizes to the intermediate compartment and to the Golgi apparatus and is able to recruit its active phosphatase partners MTMR6 and MTMR8 to these locations" — i.e., MTMR9 acts as an adaptor, not an enzyme.

Finding 2 — Family-wide catalytic-loop panel places the target unambiguously in the inactive subfamily

To confirm the diagnostic is not an artifact of comparing against only two enzymes, the catalytic loop was compared across 15 human myotubularins, anchored on the invariant histidine scaffold. The result is a clean binary split:

All nine catalytically active members carry the nucleophilic cysteine immediately after the anchoring histidine; all five known pseudophosphatases lack it. The Mytilus target has glycine at that position, grouping it unambiguously with the inactive subfamily and excluding it from the active-enzyme class. Presence/absence of the catalytic cysteine is the accepted family-level discriminator (PMID: 22647598).

Finding 3 — Exact human paralog unresolved; AlphaFold model exists but cannot rescue absent residues

A 4-mer Jaccard comparison of the target's C-terminal phosphatase-domain region against all 15 human myotubularins produced uniformly near-noise similarity (maximum Jaccard 0.026 — 14 shared 4-mers, vs MTM1; all others ≤0.022). The ranking does not cleanly favor MTMR9, so the automated "Myotubularin-related protein 9" name is not corroborated at the paralog level and should be treated as provisional. This is a naming/subfamily caveat only: the catalytic verdict rests on absence of the catalytic cysteine/arginine, which is independent of which specific human paralog is closest, since all candidate inactive paralogs equally lack the catalytic cysteine.

AlphaFold DB does host a model for this accession (AF-A0A8B6GS20-F1, Monomer v2.0, 2022-06-01). Structural geometry cannot restore catalytic function: the nucleophilic cysteine and catalytic arginine are simply absent from the sequence (P-loop = VLVH-GSEGFDTT), so there is no thiolate to position in an active site regardless of how well-folded the domain is. A predicted 3D model of a pseudophosphatase fold is not evidence of enzymatic activity.

Separately, the target has an atypical N-terminal architecture — three zona-pellucida / D8C_UMOD-like repeats (IPR057774, PF23283, MatchStatus 2) — that is absent from vertebrate MTMR9 (which carries an N-terminal PH-GRAM domain). This may indicate a divergent mollusc architecture or a mis-joined gene model. Either way, the C-terminal myotubularin domain is unambiguously catalytically degenerate.

Mechanistic Model / Interpretation

Myotubularin catalysis follows the canonical two-step PTP mechanism, which requires the intact CX₅R(T/S) P-loop:

   ACTIVE MYOTUBULARIN (e.g., MTM1, MTMR2)
   ---------------------------------------
PtdIns3P (3-phosphate)
      |
      v
     [ Cys-S(-) ]  nucleophilic attack --> covalent phospho-Cys intermediate
Arg(+)     stabilizes transition-state oxyanion
Asp        general acid/base
      |
      v
PtdIns  +  Pi     (PI3P dephosphorylated)


   TARGET A0A8B6GS20  (P-loop = VLVH-GSEGFDTT)
   ------------------------------------------
PtdIns3P
      |
      X   no Cys thiolate  (C -> G)
      X   no catalytic Arg (R -> T)
      |
No catalysis possible  ==>  PSEUDOPHOSPHATASE

The biological role of catalytically dead myotubularins is not "nothing." Across the family, pseudophosphatase members act as obligate regulatory partners of active members: catalytically inactive MTMR5 binds MTMR2, increases its activity, and dictates its localization (PMID: 12668758); MTMR13/SBF2 partners MTMR2 and, when mutated, causes CMT4B2 despite being catalytically inactive (PMID: 12687498); and MTMR9 heterodimerizes with, and dictates the activity/substrate specificity/localization of, MTMR6, MTMR7, and MTMR8 (PMID: 22647598), while also regulating ER-to-Golgi trafficking and WNT3A secretion (PMID: 31704058).

The most defensible model for A0A8B6GS20 is therefore: a myotubularin-fold protein that has lost direct PI3P phosphatase activity and most likely functions as a non-catalytic adaptor/regulator within a myotubularin heterodimer, plausibly contributing to phosphoinositide/membrane-trafficking pathways indirectly through an active partner rather than by dephosphorylating PtdIns3P itself.

Evidence Base

GO Curation Implications (leads — require curator verification)

• GO:0004438 (PI3P phosphatase activity, MF): do NOT assign as a direct molecular function. The catalytic residues required for this activity (nucleophilic Cys and transition-state Arg of the CX₅R(T/S) P-loop) are absent (C→G, R→T). The ProtNLM2 prediction is an over-annotation driven by whole-domain/fold homology (the protein is a myotubularin by fold) without checking active-site integrity — the classic pseudophosphatase misassignment. If any myotubularin MF term is used, it should carry a NOT qualifier or be omitted.
• Preferred alternative annotation: capture the non-catalytic role rather than the uninformative "protein binding." The informative direction is regulation/potentiation of a phosphoinositide phosphatase via heterodimerization (a phosphatase-activator/regulator MF, or an adaptor-in-complex annotation) — flagged as a lead based on human MTMR9 data (PMID: 22647598, PMID: 31704058), contingent on confirming ortholog identity and partner conservation in Mytilus.
• BP leads (by orthology, non-core): phosphatidylinositol-mediated signaling, ER-to-Golgi vesicle-mediated transport, regulation of protein secretion — plausible but downstream and organism-unverified; mark inferred-from-ortholog, low confidence.
• Provenance note: IPR030564/PS51339 correctly place the protein in the myotubularin family, but family membership alone does not justify the catalytic MF because this member is a pseudophosphatase.
• Name caveat: the automated "Myotubularin-related protein 9" is not corroborated at the paralog level (k-mer similarity near noise). Recommend a more conservative "myotubularin-family pseudophosphatase (subfamily unresolved)."

Mechanistic Scope

• Immediate molecular function tested: intrinsic 3-phosphatase hydrolysis of PtdIns3P at the D-3 position via the PTP-like CX₅R P-loop (Cys nucleophile + Arg oxyanion stabilization). This specific activity fails — the active site is dead.
• Adaptor/regulatory activity: heterodimerization with and modulation of active MTMRs — plausible by orthology, not directly tested in Mytilus.
• Pathway consequences (downstream, not direct): altered PI(3,4,5)P₃/AKT signaling and T-cell differentiation on MTMR9 knockdown (PMID: 23630283); ER-Golgi trafficking and autophagy modulation — these are consequences of the adaptor role and must not be recorded as this gene's direct catalytic function.
• Disease associations of family pseudophosphatases (e.g., CMT4B2 for MTMR13) — paralog- and organism-specific, and not evidence of intrinsic catalysis.

A curator should treat only the "direct activity" line as bearing on the GO:0004438 MF decision.

Conflicts and Alternatives

1. Fold-based homology vs active-site reality. The strongest apparent "support" for the prediction is that A0A8B6GS20 genuinely is a myotubularin by every domain signature. This is exactly the trap that produces pseudophosphatase over-annotation: automated pipelines project the family's modal function (active phosphatase) onto every member. The active-site check breaks the tie decisively against catalysis.
2. Paralog confusion. The k-mer analysis could not confirm MTMR9 specifically (Jaccard ≤0.026). The target could be closer to a different inactive myotubularin (MTMR11/12, or an invertebrate-specific subfamily). This changes the name and specific BP leads, not the catalytic verdict.
3. Atypical N-terminal architecture. The ZP/D8C_UMOD repeats (IPR057774, PF23283) are not part of vertebrate MTMR9, which has an N-terminal PH-GRAM domain. This raises the possibility of a divergent mollusc architecture or a mis-joined gene model; either way the C-terminal phosphatase domain is degenerate.
4. Indirect PI-pathway effects mistaken for direct activity. MTMR9 loss-of-function alters PIP3/AKT signaling (PMID: 23630283); a reader could misread this as "MTMR9 regulates phosphoinositides → therefore a PI phosphatase." The mechanism is regulatory (via active partners), not enzymatic.
5. No competing evidence for retained activity. Even human MTMR9 lacks the P-loop, so there is no basis to expect the Mytilus protein to be active.

Limitations and Knowledge Gaps

Discriminating Tests

The following would most efficiently confirm or overturn the verdict:

1. Recombinant phosphatase assay. Express the phosphatase domain and test PtdIns3P / PtdIns(3,5)P₂ dephosphorylation (malachite green / BODIPY-PI3P), with an active MTMR (e.g., MTMR2) as positive control. Prediction: no activity. The single most decisive experiment.
2. Active-site rescue control. Introduce G→C and T→R substitutions to restore the CX₅R(T/S) P-loop and re-assay; recovery of activity would confirm these residues are the sole reason for inactivity.
3. Phylogenetic placement. Build an MSA of the target with all human myotubularins plus other bivalve/invertebrate myotubularins and infer an ML tree to identify the true subfamily (active vs inactive) and settle the "MTMR9" name.
4. Partner interaction screen. AlphaFold-Multimer and/or co-IP of the target against Mytilus active myotubularins to test the adaptor hypothesis; assay whether it potentiates a partner's activity (as MTMR9 does).
5. hmmscan / active-site profile & AlphaFold active-site inspection. Quantify Pfam PF06602 / PROSITE PS51339 hits, confirm P-loop coordinates, and superpose the AF model on MTM1 to confirm no cryptic Cys/Arg occupies the catalytic pocket.

Proposed Follow-up Actions (Curation Leads — verify before applying)

• Action change: Reject/withhold GO:0004438 as a direct MF for A0A8B6GS20; do not carry the ProtNLM2 prediction into the review as asserted function. Consider a NOT-qualified or omitted phosphatase MF, and reclassify as a pseudophosphatase.
• Candidate references + exact snippets to verify:
• PMID 22647598 — "Seven members are inactive because they lack the conserved cysteine residue in the CX(5)R motif required for activity."
• PMID 22647598 — "all of which dimerize with the catalytically inactive MTMR9"
• PMID 31704058 — "the inactive phosphatase MTMR9…is able to recruit its active phosphatase partners MTMR6 and MTMR8 to these locations"
• Candidate replacement/new terms (leads): pseudophosphatase adaptor MF (phosphatase regulator/activator); phosphoinositide-metabolism / ER-to-Golgi transport BP; Golgi / ER-Golgi-intermediate-compartment CC — all by-orthology, contingent on confirming ortholog identity in Mytilus.
• Suggested questions for curator: Is the automated "MTMR9" call supported by phylogeny? Is the ZP/D8C N-terminus a real fusion or a gene-model artifact? Are Mytilus MTMR6/7/8 partners present?
• Suggested experiments: in vitro PI3P phosphatase assay (expect negative) ± active-site rescue; partner co-IP; AlphaFold active-site inspection.

Bottom Line

The myotubularin catalytic CX₅R(T/S) P-loop is degenerate in A0A8B6GS20 (Cys→Gly, Arg→Thr; CSDGWDRT → GSEGFDTT), with no intact CX₅R(T/S) motif anywhere in the sequence. Combined with the well-documented catalytic death of its named ortholog MTMR9, the ProtNLM2 PI3P-phosphatase prediction (GO:0004438) is refuted — this is a pseudophosphatase, and the term should not be assigned as a direct molecular function. A non-catalytic adaptor/pseudophosphatase role is the biologically supported alternative, and the "MTMR9" name should be treated as provisional pending phylogenetic confirmation.

Artifacts

• OpenScientist final report
• OpenScientist final report